Position in PSNL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,911,000
New position
Shares Held
300,000
first reported quarter
Ownership
0.281%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $618,295,595 across 13 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
406,154 | $203,629,369 | |
| 2 | DHR |
Danaher Corp /De/
|
452,595 | $86,210,295 | |
| 3 | GH |
Guardant Health, Inc.
|
371,763 | $55,775,602 | |
| 4 | WAT |
Waters Corp /De/
|
144,556 | $54,214,282 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
213,480 | $48,415,129 | |
| 6 | A |
Agilent Technologies, Inc.
|
321,166 | $42,660,479 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
70,301 | $37,009,258 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
21,776 | $27,819,057 |
All Filings in PSNL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,911,000 | 300,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||